Skip to main content
. 2018 Feb 2;9(38):25025–25033. doi: 10.18632/oncotarget.24382

Figure 2. Ovarian cancer penetrance estimates by the modified kin-cohort method using data from first-degree relatives of probands who carry BRCA1 or BRCA2 mutations from Hong Kong Hereditary and High Risk Breast Cancer Programme.

Figure 2